Moximed is committed to protecting its innovations through its effort in securing patent protection in the United States and other territories internationally.
Pursuant to 35 U.S.C. § 287(a) regarding patent law, the following provides notice of Moximed’s rights in the below identified United States Patents, and their foreign counterparts, and are listed in relation to the product name. Additional U.S. and non-U.S. patent applications may be pending.
The following list is not exhaustive, and other products not listed here may be protected by one or more patents in the United States and elsewhere.